Sexual Violence and Low Rates of HIV Post-exposure Prophylaxis Access Among Female Sex Workers in Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER/PLENUM PUBLISHERS
Autores
LIMA, Acacia Mayra Pereira de
MAGNO, Laio
LUPPI, Carla Gianna
SZWARCWALD, Celia Landmann
SANTANA, Elis Passos
DOURADO, Ines
Citação
AIDS AND BEHAVIOR, v.26, n.12, p.4082-4092, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Female sex workers (FSW) are disproportionately affected by sexual violence (SV) and HIV. Social and structural barriers limit their access to post-exposure prophylaxis (PEP). Respondent-driven sampling survey in 12 Brazilian cities among 4188 FSW aimed to estimate the rates of SV and factors associated with access to PEP use among FSW who experienced SV. The prevalence of SV was 26.3% (1199). Of the 1199, 7.5% sought out healthcare and used PEP, 19% sought out healthcare, but did not use PEP, and 73.5% did not seek out healthcare after SV. Factors associated with PEP use included PEP awareness, participation in HIV/STI prevention workshops, and disclosure of FSW status in healthcare services. Although Brazil has a PEP program free of charge, it is not readily accessible, even for FSW who seek out healthcare. The development of effective strategies to link FSW to HIV preventive services is urgently needed.
Palavras-chave
Female sex workers, Sexual violence, HIV, Post-exposure prophylaxis, Respondent-driven sampling, Brazil
Referências
  1. ABIA. Associao Brasileira Interdisciplinar de AIDS, 2014, POLT SAD RESP HIV PR
  2. Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X
  3. Barreto, 2008, PROSTITUIO GNERO SEX
  4. Benn P, 2011, INT J STD AIDS, V22, P695, DOI 10.1258/ijsa.2011.171011
  5. Blanchard AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-234
  6. Blanchette T., 2017, CRIMINAL JUSTICE LAW, V7, P31
  7. Boccolini CS, 2016, CIENC SAUDE COLETIVA, V21, P371, DOI 10.1590/1413-81232015212.19412015
  8. Bortoli, 2016, J NURS UFPE, V10, P7
  9. Brasil, 2015, PORTARIA 34 22 JULHO
  10. Brasil. Ministrio da Sade. Programa Nacional de DST e AIDS, 2006, B EPID AIDSDST
  11. Brasil. Ministrio da Sade. Secretaria de Vigilncia em Sade, DEPARTAMENTO VIGILNC
  12. Cohen SE, 2013, AM J PREV MED, V44, pS80, DOI 10.1016/j.amepre.2012.09.036
  13. CorrUa S., 2014, THE BUSINESS OF SEX, P175
  14. Damacena Giseli Nogueira, 2019, Rev. bras. epidemiol., V22, pe190002, DOI 10.1590/1980-549720190002.supl.1
  15. Damacena GN, 2011, JAIDS-J ACQ IMM DEF, V57, pS144, DOI 10.1097/QAI.0b013e31821e9bf6
  16. Decker MR, 2015, LANCET, V385, P186, DOI 10.1016/S0140-6736(14)60800-X
  17. Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909
  18. dos Santos IB, 2020, CIENC SAUDE COLETIVA, V25, P1935, DOI 10.1590/1413-81232020255.19752018
  19. Dourado I, 2019, BMC INT HEALTH HUM R, V19, DOI 10.1186/s12914-019-0193-7
  20. Ferraz D, 2019, SEX REPROD HLTH MATT, V27, P107, DOI 10.1080/26410397.2019.1650587
  21. Filgueiras Sandra Lúcia, 2018, Sex., Salud Soc. (Rio J.), P282, DOI 10.1590/1984-6487.sess.2018.30.14.a
  22. Gehlen, 2018, CIENCIA ENFERMEIRA, V24, P1
  23. Goldenberg SM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2491-x
  24. Gouveia Giselle Campozana, 2005, Cad. Saúde Pública, V21, pS109, DOI 10.1590/S0102-311X2005000700012
  25. Izulla P, 2013, JAIDS-J ACQ IMM DEF, V62, P220, DOI 10.1097/QAI.0b013e318278ba1b
  26. Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200
  27. Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9
  28. Kerrigan D, 2008, HEALTH EDUC RES, V23, P137, DOI 10.1093/her/cym011
  29. Krusi A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005191
  30. Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411
  31. Levy J, 2014, CRIMINOL CRIM JUSTIC, V14, P593, DOI 10.1177/1748895814528926
  32. Lippman SA, 2010, AM J PUBLIC HEALTH, V100, pS216, DOI 10.2105/AJPH.2008.147462
  33. da Silva LEL, 2016, EPIDEMIOL SERV SAUDE, V25, P331, DOI [10.5123/s1679-49742016000200012, 10.5123/S1679-49742016000200012]
  34. Lyons CE, 2017, JAIDS-J ACQ IMM DEF, V75, P9, DOI [10.1097/QAI.0000000000001310, 10.1097/qai.0000000000001310]
  35. Martins TA, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000300, 10.11606/s1518-8787.2018052000300]
  36. Minas B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-906
  37. Montenegro L, 2020, AIDS BEHAV, V24, P1, DOI 10.1007/s10461-019-02470-3
  38. Urzúa Morales Alfonso, 2008, Rev. Saúde Pública, V42, P822, DOI 10.1590/S0034-89102008000500006
  39. O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
  40. Olsthoorn AV, 2016, AIDS, V30, P99, DOI 10.1097/QAD.0000000000000884
  41. Olufunmilayo IF, 2014, AFR HEALTH SCI, V14, P299, DOI 10.4314/ahs.v14i2.4
  42. Pan American Health Organization, THIS OR DAY PAHO WHO
  43. Panchanadeswaran S, 2008, INT J DRUG POLICY, V19, P106, DOI 10.1016/j.drugpo.2007.11.013
  44. Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059
  45. Platt L, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002680
  46. Prangnell A, 2018, J PUBLIC HEALTH POL, V39, P86, DOI 10.1057/s41271-017-0098-4
  47. Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513
  48. Ramos DH., 2019, DIREITO CIDADE ESTIG
  49. Restar AJ, 2017, AIDS EDUC PREV, V29, P141, DOI 10.1521/aeap.2017.29.2.141
  50. Mathias AKRD, 2013, REV BRAS GINECOL OBS, V35, P185, DOI 10.1590/S0100-72032013000400009
  51. Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x
  52. Seffner F, 2016, INTERFACE-BOTUCATU, V20, P293, DOI 10.1590/1807-57622015.0459
  53. Shannon K, 2018, LANCET, V392, P698, DOI 10.1016/S0140-6736(18)31439-9
  54. Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4
  55. Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090
  56. Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858
  57. Szwarcwald CL, 2018, MEDICINE, V97, pS54, DOI 10.1097/MD.0000000000009013
  58. Urada LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033282
  59. Villela WV, 2015, EPIDEMIOL SERV SAUDE, V24, P531, DOI 10.5123/S1679-49742015000300019
  60. Wanyenze RK, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0119-1